Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis

Clinical trial NCT07203391 · RECRUITING

Trial details

NCT number: NCT07203391
Sponsor: St Vincent's Hospital, Sydney
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Uveal Melanoma, Metastatic

Start date: 2026-02-01
Primary completion: 2027-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.